J. Mark Ray

J. Mark Ray

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Posts › Centers for Disease Control and Prevention (CDC)

Share:

Alston & Bird Health Care Week in Review - December 2020 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/21/2020  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Provider Relief Fund , Vaccinations

Alston & Bird Health Care Week in Review - December 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

12/7/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Outpatient Services , Physician Fee Schedule , Vaccinations , Virus Testing

Alston & Bird Health Care Week in Review - October 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/26/2020  /  CARES Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Provider Relief Fund

Alston & Bird Health Care Week in Review - October 2020 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/19/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Telehealth

Alston & Bird Health Care Week in Review - October 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/5/2020  /  CARES Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Provider Relief Fund

Alston & Bird Health Care Week in Review - September 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/28/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Hospitals , Medicaid , Medical Devices , Medicare , Trump Administration , Vaccinations

Alston & Bird Health Care Week in Review - September 2020 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/21/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare

Alston & Bird Health Care Week in Review - September 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/14/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Vaccinations

Alston & Bird Health Care Week in Review - September 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/8/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Physicians , Public Health , Public Health Emergency , Vaccinations , Virus Testing

Alston & Bird Health Care Week in Review - August 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/31/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , Public Health

Alston & Bird Health Care Week in Review - August 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/17/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Rural Health Care Providers , SAMHSA

Alston & Bird Healthcare Week in Review - February 2020 #4

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

3/2/2020  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Trade Commission (FTC) , HRSA

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

2/3/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/9/2019  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Healthcare , HRSA , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/3/2019  /  Center for Drug Evaluation and Research (CDER) , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medical Devices , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/19/2019  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Medicare Part D , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , SAMHSA

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

5/20/2019  /  Abbreviated New Drug Application (ANDA) , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , Prescription Drugs

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

4/15/2019  /  Abbreviated New Drug Application (ANDA) , Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

11/19/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , PDUFA , Pharmaceutical Industry

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

10/1/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drug Coverage , Prescription Drugs , Section 503

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

9/10/2018  /  Centers for Disease Control and Prevention (CDC) , Draft Guidance , Food and Drug Administration (FDA) , GAO , HRSA , MedPAC , Opioid

Alston & Bird Healthcare Week In Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

3/19/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , HRSA , Medical Devices

Alston & Bird Healthcare Week In Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

3/12/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , HRSA , SAMHSA

Alston & Bird Healthcare Week In Review

I. Regulations, Notices, & Guidance - On February 12, 2018, the Food and Drug Administration (FDA) issued a guidance entitled, Bacillus Calmette-Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and...more

2/20/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , HRSA , Inpatient Prospective Payment System (IPPS) , OIG , SAMHSA

Alston & Bird Healthcare Week In Review

On January 16, 2018, the Food and Drug Administration (FDA) issued a proposed rule entitled, Internal Agency Review of Decisions; Requests for Supervisory Review of Certain Decisions Made by the Center for Devices and...more

1/23/2018  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , HRSA , Inpatient Prospective Payment System (IPPS) , Medicare , OCR , REMS , SAMHSA
58 Results
 / 
View per page
« Previous
Page: of 3
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide